To determine whether spliced variants exist that are specifically expressed in prostate cancers, we carried out reverse transcribed polymerase chain reaction (rt-PCR) on mRNA isolated from prostate tumor cell lines using primers in exons 1, 2 and 8 of the AGR2 gene. The gene discussed is AGR2; the disease is prostate neoplasm.